002932 明德生物
2024/06 - 中期
人民币(K¥)
与去年末期
比较
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)

非流动资产
长期股权投资145,456-0.62%146,35847,09352,22337,999
投资性房地产0--0000
固定资产309,797-7.53%335,034367,288155,244104,236
在建工程280,20051.31%185,185121,51873,58019,020
无形资产17,148-3.11%17,69916,86216,59516,932
商誉0--0000
其他非流动资产3,796,766-3.94%3,952,399960,046119,36930,355
4,549,367-1.88%4,636,6751,512,807417,011208,542

流动资产
货币资金778,450-23.36%1,015,6832,555,5551,190,105669,111
应收账款990,157-18.12%1,209,3502,559,581738,757180,678
存货123,502-4.09%128,769258,435284,595117,732
其他流动资产491,94624.19%396,1232,308,278786,622250,582
2,384,055-13.30%2,749,9247,681,8493,000,0791,218,104

流动负债
短期借款3,000-87.30%23,614164,66830,000141,500
应付票据20,743--0000
应付帐款472,568-30.67%681,5791,293,855174,30830,944
其他流动负债234,549-25.34%314,170906,414341,674136,980
730,860-28.30%1,019,3622,364,937545,982309,424
流动资产净值1,653,195-4.47%1,730,5625,316,9112,454,097908,680
资产总额减流动负债6,202,562-2.59%6,367,2386,829,7182,871,1071,117,222

非流动负债
长期借款0--0000
应付债券0--0000
其他非流动负债73,909-1.63%75,13657,78521,0342,343
73,909-1.63%75,13657,78521,0342,343

总权益
    实收股本232,5210.00%232,521156,193104,87869,005
    储备项目5,666,075-2.20%5,793,3696,343,8192,683,9471,032,788
股东权益5,898,596-2.11%6,025,8906,500,0122,788,8251,101,793
非控股权益230,057-13.58%266,212271,92161,24913,086